Skip to main content

Together we are beating cancer

Donate now

Cancer News

Analysis

Showing 12 out of 2540 results
Professor Carolyn Bertozzi with graduate student Mireille Kamariza

Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children. Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children.

by Tim Gunn | Analysis | 8 November 2022

8 November 2022

Tissue stain of medulloblastoma - which is densely cellular and discrete from other tissue

Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future. Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.

by Lilly Matson | Analysis | 4 November 2022

4 November 2022

The House of Parliament in London

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

by Jacob Smith | Analysis | 1 November 2022

1 November 2022

A 3D illustration of cancer cells

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

by Jacob Smith | Analysis | 18 October 2022

18 October 2022

A graphic depicting a shadow in the shape of DNA overlaying strings of genetic code

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.   A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.  

by Jacob Smith | Analysis | 12 October 2022

12 October 2022

A photo of a person with their back to the camera, standing in front of a cigarette dispenser.

In the last 2 years, our partner, the Nepal Development Research Institute, have successfully advocated for increases in tobacco tax in Nepal. In the last 2 years, our partner, the Nepal Development Research Institute, have successfully advocated for increases in tobacco tax in Nepal.

by Beth Turner | Analysis | 30 September 2022

30 September 2022

This entry is part 2 of 3 in the series CRUK Global
A photograph of a mobile mammogram unit.

In this instalment of our Health Inequalities series, we take a look at some of the barriers that can make it harder for some people to access cancer screening. In this instalment of our Health Inequalities series, we take a look at some of the barriers that can make it harder for some people to access cancer screening.

by Julia Cotterill | Analysis | 23 September 2022

23 September 2022

This entry is part 4 of 5 in the series Health inequalities
A photograph of someone holding a test tube in a lab.

We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma. We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma.

by Lilly Matson | Analysis | 22 September 2022

22 September 2022

The theme for this year’s Peer Review Week is ‘research integrity’ – that really strikes a chord with our new columnists… The theme for this year’s Peer Review Week is ‘research integrity’ – that really strikes a chord with our new columnists…

by Phil Prime | Analysis | 21 September 2022

21 September 2022

This entry is part 8 of 18 in the series Research Integrity
A photo of Katie Currie with her mum and sister

In an unusual turn of events, the results of a clinical trial for mitoxantrone turned out to be so effective that the randomisation of the trial was halted early.  In an unusual turn of events, the results of a clinical trial for mitoxantrone turned out to be so effective that the randomisation of the trial was halted early. 

by Lilly Matson | Analysis | 16 September 2022

16 September 2022